+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Breast Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 353 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5934290
Description Jump to:

Advancements in Diagnosis and Treatment Drive Growth in Breast Biopsy Market

Increasing Prevalence of Breast Cancer and Growing Demand for Minimally-Invasive Techniques

In today's world, lifestyle factors and behavioral patterns play a significant role in the worsening of breast cancer. With obesity linked to higher insulin levels, the correlation between lifestyle choices and cancer risk is becoming clearer. Consequently, the demand for breast biopsy procedures, essential for confirming cancerous lesions, is on the rise.

According to statistics from the National Breast Cancer Foundation (2022), the United States alone witnesses a staggering number of breast cancer diagnoses, with a woman diagnosed approximately every 2 minutes. Moreover, the incidence of invasive breast cancer in 2022 reached nearly 287,500 cases, with 43,550 resulting in fatalities.

One key driver of the increased demand for breast biopsy procedures is the emphasis on early detection and screening programs. Regular mammography screenings and heightened awareness campaigns have led to the identification of breast abnormalities at earlier stages, necessitating further evaluation through biopsies.

The shift towards minimally invasive biopsy techniques, such as core needle biopsy and vacuum-assisted biopsy, has gained momentum due to their accuracy, reduced discomfort, and faster recovery times. As a result, the prevalence of breast cancer directly impacts the demand for biopsy procedures, prompting ongoing research and development efforts to enhance techniques and technologies.

Factors Contributing to the Demand Growth for Breast Biopsy Procedures

The demand for breast biopsy procedures is bolstered by the increasing prevalence of breast cancer globally. As companies focus on technological advancements, opportunities arise for the development of more precise biopsy devices and companion diagnostic tools. Moreover, the trend towards personalized medicine presents avenues for targeted therapies and individualized treatment approaches.

Hindrances to the Adoption of Breast Biopsy

Despite the increasing demand, barriers to adoption persist. The high cost of equipment and lack of infrastructure pose challenges, particularly in regions with financial constraints. Additionally, regulatory complexities and reimbursement policies vary, impacting the accessibility of advanced biopsy techniques.

Country-wise Insights

  • United States: With advanced diagnostic methods and favorable reimbursement practices, the U.S. remains a lucrative market for breast biopsy equipment manufacturers.
  • China: Increasing government investments in healthcare infrastructure drive growth opportunities, supported by technological advancements and awareness initiatives.
  • United Kingdom: Strong research and innovation contribute to the development of new biopsy technologies, with emphasis on early detection and treatment awareness.

Category-wise Insights

  • Breast Biopsy Needles: Cost-effectiveness and ease of use drive high sales in this segment, constituting a significant portion of the global market.
  • Indications: The increasing utilization of breast biopsy equipment for diagnosing complex cysts occupies a leading share of the market.

Competitive Analysis

Key manufacturers continue to innovate, launching novel products to detect breast cancer. Mergers and acquisitions remain strategic avenues for established players to strengthen their market position.

Key Companies Covered

  • Argon Medical
  • Becton Dickinson and Company
  • C.R. Bard, Inc.
  • Cook Medical Inc.
  • Devicor Medical Products, Inc.
  • F. Hoffmann-La Roche Ltd.,
  • GE Healthcare
  • Hologic, Inc.
  • Leica Biosystems
  • Medax Srl Unipersonale
  • Planmed Oy
  • Scion Medical Technologies, LLC
  • Siemens Healthineers
  • Hikma Pharmaceuticals
  • Incytes

Key Segments of Breast Biopsy Industry

Product:

  • Biopsy Needles
  • Core Needles
  • Fine Aspiration Needles
  • MRI-Guide Biopsy Systems
  • Ultrasound Guided Breast Biopsy Systems
  • Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
  • Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
  • Vacuum-Assisted Devices (VAD)
  • Guide Wire (Localization Wire)
  • Breast Biopsy Markers

Indication:

  • Complex Cysts
  • Solid Mass
  • Suspicious Solid Mass (Fibroadenoma)
  • Suspicious Micro-calcifications

End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Breast Biopsy Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Price Analysis, 2018 - 2023
3.1. Global Average Price Analysis, by Product/ Indication, US$ Per Unit, 2018 - 2023
3.2. Prominent Factor Affecting Breast Tissue Markers Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit
4. Global Breast Biopsy Market Outlook, 2018 - 2031
4.1. Global Breast Biopsy Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Biopsy Needles
4.1.1.1.1. Core Needles
4.1.1.1.2. Fine Aspiration Needles
4.1.1.2. MRI-Guide Biopsy Systems
4.1.1.3. Ultrasound Guided Breast Biopsy Systems
4.1.1.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
4.1.1.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
4.1.1.4. Vacuum-Assisted Devices (VAD)
4.1.1.5. Guide Wire (Localization Wire)
4.1.1.6. Breast Biopsy Markers
4.2. Global Breast Biopsy Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Complex Cysts
4.2.1.2. Solid Mass
4.2.1.3. Suspicious Solid Mass (Fibroadenoma)
4.2.1.4. Suspicious Micro-calcifications
4.3. Global Breast Biopsy Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Specialty Clinics
4.3.1.3. Ambulatory Surgical Centers
4.3.1.4. Cancer Research Institutes
4.4. Global Breast Biopsy Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. North America
4.4.1.2. Europe
4.4.1.3. Asia Pacific
4.4.1.4. Latin America
4.4.1.5. Middle East & Africa
5. North America Breast Biopsy Market Outlook, 2018 - 2031
5.1. North America Breast Biopsy Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Biopsy Needles
5.1.1.1.1. Core Needles
5.1.1.1.2. Fine Aspiration Needles
5.1.1.2. MRI-Guide Biopsy Systems
5.1.1.3. Ultrasound Guided Breast Biopsy Systems
5.1.1.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
5.1.1.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
5.1.1.4. Vacuum-Assisted Devices (VAD)
5.1.1.5. Guide Wire (Localization Wire)
5.1.1.6. Breast Biopsy Markers
5.2. Global Breast Biopsy Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Complex Cysts
5.2.1.2. Solid Mass
5.2.1.3. Suspicious Solid Mass (Fibroadenoma)
5.2.1.4. Suspicious Micro-calcifications
5.3. Global Breast Biopsy Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Specialty Clinics
5.3.1.3. Ambulatory Surgical Centers
5.3.1.4. Cancer Research Institutes
5.4. North America Breast Biopsy Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. U.S. Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1.2. U.S. Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1.3. U.S. Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1.4. Canada Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1.5. Canada Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1.6. Canada Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Europe Breast Biopsy Market Outlook, 2018 - 2031
6.1. Europe Breast Biopsy Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Biopsy Needles
6.1.1.1.1. Core Needles
6.1.1.1.2. Fine Aspiration Needles
6.1.1.2. MRI-Guide Biopsy Systems
6.1.1.3. Ultrasound Guided Breast Biopsy Systems
6.1.1.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
6.1.1.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
6.1.1.4. Vacuum-Assisted Devices (VAD)
6.1.1.5. Guide Wire (Localization Wire)
6.1.1.6. Breast Biopsy Markers
6.2. Global Breast Biopsy Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Complex Cysts
6.2.1.2. Solid Mass
6.2.1.3. Suspicious Solid Mass (Fibroadenoma)
6.2.1.4. Suspicious Micro-calcifications
6.3. Global Breast Biopsy Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Specialty Clinics
6.3.1.3. Ambulatory Surgical Centers
6.3.1.4. Cancer Research Institutes
6.4. Europe Breast Biopsy Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Germany Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.2. Germany Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.3. Germany Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.4. U.K. Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.5. U.K. Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.6. U.K. Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.7. France Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.8. France Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.9. France Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.10. Italy Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.11. Italy Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.12. Italy Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.13. Turkey Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.14. Turkey Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.15. Turkey Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.16. Russia Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.17. Russia Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.18. Russia Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.19. Rest of Europe Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.20. Rest of Europe Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.21. Rest of Europe Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Asia Pacific Breast Biopsy Market Outlook, 2018 - 2031
7.1. Asia Pacific Breast Biopsy Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Biopsy Needles
7.1.1.1.1. Core Needles
7.1.1.1.2. Fine Aspiration Needles
7.1.1.2. MRI-Guide Biopsy Systems
7.1.1.3. Ultrasound Guided Breast Biopsy Systems
7.1.1.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
7.1.1.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
7.1.1.4. Vacuum-Assisted Devices (VAD)
7.1.1.5. Guide Wire (Localization Wire)
7.1.1.6. Breast Biopsy Markers
7.2. Global Breast Biopsy Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Complex Cysts
7.2.1.2. Solid Mass
7.2.1.3. Suspicious Solid Mass (Fibroadenoma)
7.2.1.4. Suspicious Micro-calcifications
7.3. Global Breast Biopsy Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Specialty Clinics
7.3.1.3. Ambulatory Surgical Centers
7.3.1.4. Cancer Research Institutes
7.4. Asia Pacific Breast Biopsy Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. China Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.2. China Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.3. China Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.4. Japan Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.5. Japan Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.6. Japan Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.7. South Korea Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.8. South Korea Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.9. South Korea Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.10. India Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.11. India Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.12. India Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.13. Southeast Asia Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.14. Southeast Asia Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.15. Southeast Asia Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.16. Rest of Asia Pacific Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.17. Rest of Asia Pacific Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.18. Rest of Asia Pacific Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Latin America Breast Biopsy Market Outlook, 2018 - 2031
8.1. Latin America Breast Biopsy Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Biopsy Needles
8.1.1.1.1. Core Needles
8.1.1.1.2. Fine Aspiration Needles
8.1.1.2. MRI-Guide Biopsy Systems
8.1.1.3. Ultrasound Guided Breast Biopsy Systems
8.1.1.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
8.1.1.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
8.1.1.4. Vacuum-Assisted Devices (VAD)
8.1.1.5. Guide Wire (Localization Wire)
8.1.1.6. Breast Biopsy Markers
8.2. Global Breast Biopsy Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Complex Cysts
8.2.1.2. Solid Mass
8.2.1.3. Suspicious Solid Mass (Fibroadenoma)
8.2.1.4. Suspicious Micro-calcifications
8.3. Global Breast Biopsy Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Specialty Clinics
8.3.1.3. Ambulatory Surgical Centers
8.3.1.4. Cancer Research Institutes
8.4. Latin America Breast Biopsy Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Brazil Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.2. Brazil Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.3. Brazil Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.4. Mexico Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.5. Mexico Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.6. Mexico Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.7. Argentina Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.8. Argentina Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.9. Argentina Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.10. Rest of Latin America Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.11. Rest of Latin America Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.12. Rest of Latin America Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Middle East & Africa Breast Biopsy Market Outlook, 2018 - 2031
9.1. Middle East & Africa Breast Biopsy Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Biopsy Needles
9.1.1.1.1. Core Needles
9.1.1.1.2. Fine Aspiration Needles
9.1.1.2. MRI-Guide Biopsy Systems
9.1.1.3. Ultrasound Guided Breast Biopsy Systems
9.1.1.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
9.1.1.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
9.1.1.4. Vacuum-Assisted Devices (VAD)
9.1.1.5. Guide Wire (Localization Wire)
9.1.1.6. Breast Biopsy Markers
9.2. Global Breast Biopsy Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.2.1. Key Highlights
9.2.1.1. Complex Cysts
9.2.1.2. Solid Mass
9.2.1.3. Suspicious Solid Mass (Fibroadenoma)
9.2.1.4. Suspicious Micro-calcifications
9.3. Global Breast Biopsy Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Hospitals
9.3.1.2. Specialty Clinics
9.3.1.3. Ambulatory Surgical Centers
9.3.1.4. Cancer Research Institutes
9.4. Middle East & Africa Breast Biopsy Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. GCC Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.2. GCC Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.3. GCC Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.4. South Africa Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.5. South Africa Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.6. South Africa Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.7. Egypt Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.8. Egypt Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.9. Egypt Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.10. Nigeria Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.11. Nigeria Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.12. Nigeria Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.13. Rest of Middle East & Africa Breast Biopsy Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.14. Rest of Middle East & Africa Breast Biopsy Market by Indication, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.15. Rest of Middle East & Africa Breast Biopsy Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Competitive Landscape
10.1. Product vs Indication Heatmap
10.2. Company Market Share Analysis, 2023
10.3. Competitive Dashboard
10.4. Company Profiles
10.4.1. Argon Medical
10.4.1.1. Company Overview
10.4.1.2. Product Portfolio
10.4.1.3. Financial Overview
10.4.1.4. Business Strategies and Development
10.4.2. Becton Dickinson and Company
10.4.2.1. Company Overview
10.4.2.2. Product Portfolio
10.4.2.3. Financial Overview
10.4.2.4. Business Strategies and Development
10.4.3. C.R. Bard, Inc.
10.4.3.1. Company Overview
10.4.3.2. Product Portfolio
10.4.3.3. Financial Overview
10.4.3.4. Business Strategies and Development
10.4.4. Cook Medical Inc.
10.4.4.1. Company Overview
10.4.4.2. Product Portfolio
10.4.4.3. Financial Overview
10.4.4.4. Business Strategies and Development
10.4.5. Devicor Medical Products, Inc.
10.4.5.1. Company Overview
10.4.5.2. Product Portfolio
10.4.5.3. Financial Overview
10.4.5.4. Business Strategies and Development
10.4.6. F. Hoffmann-La Roche Ltd.,
10.4.6.1. Company Overview
10.4.6.2. Product Portfolio
10.4.6.3. Financial Overview
10.4.6.4. Business Strategies and Development
10.4.7. GE Healthcare
10.4.7.1. Company Overview
10.4.7.2. Product Portfolio
10.4.7.3. Financial Overview
10.4.7.4. Business Strategies and Development
10.4.8. Hologic, Inc.
10.4.8.1. Company Overview
10.4.8.2. Product Portfolio
10.4.8.3. Financial Overview
10.4.8.4. Business Strategies and Development
10.4.9. Leica Biosystems
10.4.9.1. Company Overview
10.4.9.2. Product Portfolio
10.4.9.3. Financial Overview
10.4.9.4. Business Strategies and Development
10.4.10. Medax Srl Unipersonale
10.4.10.1. Company Overview
10.4.10.2. Product Portfolio
10.4.10.3. Financial Overview
10.4.10.4. Business Strategies and Development
10.4.11. Planmed Oy
10.4.11.1. Company Overview
10.4.11.2. Product Portfolio
10.4.11.3. Financial Overview
10.4.11.4. Business Strategies and Development
10.4.12. Scion Medical Technologies, LLC
10.4.12.1. Company Overview
10.4.12.2. Product Portfolio
10.4.12.3. Financial Overview
10.4.12.4. Business Strategies and Development
10.4.13. Siemens Healthineers
10.4.13.1. Company Overview
10.4.13.2. Product Portfolio
10.4.13.3. Financial Overview
10.4.13.4. Business Strategies and Development
10.4.14. Hikma Pharmaceuticals
10.4.14.1. Company Overview
10.4.14.2. Product Portfolio
10.4.14.3. Financial Overview
10.4.14.4. Business Strategies and Development
10.4.15. Incytes
10.4.15.1. Company Overview
10.4.15.2. Product Portfolio
10.4.15.3. Financial Overview
10.4.15.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations

Companies Mentioned

  • Argon Medical
  • Becton Dickinson and Company
  • C.R. Bard, Inc.
  • Cook Medical Inc.
  • Devicor Medical Products, Inc.
  • F. Hoffmann-La Roche Ltd.,
  • GE Healthcare
  • Hologic, Inc.
  • Leica Biosystems
  • Medax Srl Unipersonale
  • Planmed Oy
  • Scion Medical Technologies, LLC
  • Siemens Healthineers
  • Hikma Pharmaceuticals
  • Incytes

Methodology

Loading
LOADING...

Related Topics

Related Reports

Breast Biopsy Market by Product, Type, Guidance, Application - Global Forecast 2025-2030 - Product Image

Breast Biopsy Market by Product, Type, Guidance, Application - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Breast Biopsy Device Market by Product, Test, Guidance, End-Use - Global Forecast 2025-2030 - Product Image

Breast Biopsy Device Market by Product, Test, Guidance, End-Use - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Cancer Biopsy Market Analysis & Forecast to 2024-2034: Market By Type; By Product; By Application; and By Region - Product Image

Cancer Biopsy Market Analysis & Forecast to 2024-2034: Market By Type; By Product; By Application; and By Region

  • Report
  • 200 Pages
  • Global
From
Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2024-2032 - Product Image

Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Breast Biopsy Devices Market 2024-2028 - Product Image

Breast Biopsy Devices Market 2024-2028

  • Report
  • 201 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.